Market Place
Sourcing Support
CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™ Technology
13 Feb 2019 //
PR NEWSWIRE
European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD
11 Feb 2019 //
BUSINESSWIRE
US FDA accepts sBLA & grants priority review status for Adcetris
04 Jan 2018 //
PHARMABIZ
Seattle Genetics chalks up first clinical trial success in solid tumors
12 Dec 2016 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.